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ABSTRACT 
Sustained expression of FOXM1 is a hallmark of nearly all human cancers including squamous 
cell carcinomas of the head and neck (HNSCC). HNSCCs partially preserve the epithelial 
differentiation program, which recapitulates fetal and adult traits of the tissue of tumor origin but 
is deregulated by genetic alterations and tumor-supporting pathways. Using shRNA-induced 
knockdown, we demonstrate a minimal impact of FOXM1 on proliferation and migration of 
HNSCC cell lines under standard cell culture conditions. However, FOXM1 knockdown in three-
dimensional (3D) culture and xenograft tumor models resulted in reduced proliferation, decreased 
invasion and a more differentiated-like phenotype, indicating a context dependent modulation of 
FOXM1 activity in HNSCC cells. By ectopic overexpression of FOXM1 in HNSCC cell lines, 
we demonstrate a reduced expression of cutaneous-type keratin K1 and involucrin as a marker of 
squamous differentiation, supporting the role of FOXM1 in modulation of aberrant differentiation 
in HNSCC. Thus, our data provide a strong rationale for targeting FOXM1 in HNSCC. 
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INTRODUCTION 
Transcription factors of the Forkhead family are crucial regulators of embryonic 
development and many vital functions in adult tissues [1]. These proteins also play a pivotal role 
in the progression of cancers. The most important Forkhead Box (FOX) transcription factor 
involved in a multitude of pro-tumorigenic processes is FOXM1 [2,3]. The main gene regulatory 
activity of FOXM1 is attributed to cell cycle and mitotic control [4,5]. However, recent studies 
revealed additional activities of FOXM1 as a co-regulator of oncogenic pathways [3,6]. In 
addition, high FOXM1 expression serves as a biomarker of poor outcome across a large set of 
cancer types [7]. This strongly supports the concept of FOXM1 as an actionable target for 
therapy [3,6] and encourages further exploration of FOXM1 function. 
Squamous cell carcinomas of the head and neck (HNSCC) is a heterogeneous group of 
deadly cancers associated with loco-regional recurrences and distant metastases caused by the 
invasive and metastatic behavior of cancer cells [8]. The most striking feature of all SCCs is their 
ability to preserve a functional epithelial differentiation program [9], which recapitulates many 
specific traits of the tissue of origin of the tumor. However, in contrast to normal tissues, tight 
control over the fate and size of the proliferating and differentiating cell populations is lost in 
SCCs due to inactivation of critical regulatory mechanisms [9], thus causing aberrant epithelial 
differentiation and stratification featured in particular by altered and heterogeneous expression of 
keratins [10-12]. 
Despite a large body of evidence that FOXM1 has a role in HNSCC [13–16], its 
oncogenic functions in this type of cancer are not yet sufficiently understood. In that regard it is 
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noteworthy that FOXM1 is upregulated in premalignant oral lesions and persisting in primary 
HNSCCs and metastases [17]. Ectopic FOXM1 overexpression in oral keratinocytes induces a 
hyperproliferative phenotype and suppresses the expression of epithelial differentiation-specific 
genes [18] via a mechanism that includes differential regulation of DNA methylation [15]. Also, 
upon loss of p53 or overexpression of c-Myc, ectopic FOXM1 partially rescued primary human 
keratinocytes from terminal squamous differentiation, while promoting proliferation and genome 
instability [19]. In turn, differentiating normal human keratinocytes lose FOXM1 expression [20], 
thus suggesting that down-regulation of FOXM1 is part of the keratinocyte differentiation 
program. However, the effect of FOXM1 knockdown or overexpression on the differentiation 
state of HNSCC cells remains so far elusive. Given that FOXM1 is expressed in HNSCCs also 
early on during tumorigenesis [17,18], the demonstration of an effect on tumor growth and 
phenotype would support FOXM1 as a novel actionable target for adjuvant treatment of these 
cancers. In the present work, we thus sought to clarify the role of FOXM1 in HNSCC cell lines 
using cell culture and xenograft models. 
 
Materials and methods 
 
Cell culture 
The human CAL27 cell line was purchased from ATCC (CRL-2095) and its authenticity was 
confirmed by STR profiling (Microsynth Gmbh, Balgach, Switzerland). Other cancer cell lines 
(LAU2083, LAU2088, and LOD148) and cancer associated fibroblasts (CAF142) were 
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established from tumor biopsies from patients undergoing surgery at the CHUV hospital (the 
procedures were all approved by the Cantonal Department of the Swiss Ethics Committees and 
the relevant informed consent forms were signed by the patients). All cells were cultured in a 
humidified atmosphere of 5% CO2 at 37 °C. For a full list of the culture media used please see 
supplementary material, Supplementary materials and methods. 
 
Inducible shRNA knockdown 
Inducible FOXM1 knockdown in CAL27, LAU2083 or LOD148 cells was achieved using the 
pTRIPZ system (Dharmacon, Lafayette, CO, USA). Cells were transduced with a lentivirus 
carrying a shRNA sequence targeting FOXM1 (shFOXM1, CloneId V3THS_396939, 
Dharmacon) or a Non-silencing shRNA Control (shCtr, RHS4743, Dharmacon) and further 
selected by 1.5 µg/ml puromycin (540222-25, VWR International GmbH, Dietikon, Switzerland). 
After transient activation of the tetracycline response element by its transactivator (rtTA3) with 2 
µg/ml doxycycline (Dox, D9891, Sigma-Aldrich Chemie GmbH, Buchs SG, Switzerland) for two 
days, cells were sorted by FACS to enrich for those expressing a high level of the pTRIPZ 
reporter (TurboRFPhigh) and were further maintained without Dox. Prior to any in vitro 
experiment, cells were treated again for 5 days with 2 µg/ml Dox to induce FOXM1 down-
regulation and were further maintained in Dox-containing medium throughout the course of the 
experiment. 
 
Constitutive FOXM1 overexpression 
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Constitutive FOXM1 overexpression in CAL27, LAU2083, LAU2088 and LOD148 cells was 
achieved using the pLenti-Blast system. In brief, the lentiviral pLenti-PGK-Blast-FOXM1c 
(“FOXM1”) and pLenti-PGK-Blast-mCherry (“mCherry”) were generated by subcloning human 
FOXM1c (contains an N terminal FLAG epitope tag) and mCherry nucleotide sequences from 
pCW57.1-FOXM1c (Addgene plasmid # 68810; a gift from Adam Karpf) and LeGO-C2 vectors 
(Addgene plasmid # 27339; a gift from Boris Fehse) into pLenti-PGK-Blast-V5-LUC (w528-1) 
vector (Addgene plasmid # 19166; a gift from Eric Campeau and Paul Kaufman) by replacing 
V5-tagged firefly luciferase with the respective insert sequence. After transduction with either 
vector, cells were further selected by incubation with 5 µg/ml blasticidin (InvivoGen, Toulouse, 
France). 
 
3D cell culture (organotypic culture, spheroids and tumorspheres) 
Organotypic cell culture was performed as previously described [21] and is briefly outlined in the 
supplemental experimental procedures. After 8–16 days of culture, the organotypes were 
collected either in 4% PFA/PBS for histological staining or in TRI reagent (T9424, Sigma-
Aldrich Chemie GmbH) for RT-qPCR analysis. As a simplified version of the organotypic 
culture, cells can be embedded inside the collagen instead of on top of it, in which case cells will 
grow as spheroids. In brief, 200,000 tumor cells were admixed into a regular collagen I solution 
at a final concentration of 2.8 mg/ml before seeding them in one well of a poly-HEMA coated 
24-well plate. After 30 min at 37 °C, regular culture medium was added on top of the collagen 
and cells were kept in tissue culture plates for 9 days to allow the development of spheroids. 
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Spheroid-containing collagen gels were collected either in TRIzol for RNA analysis or with a 
PFA/Sucrose/OCT protocol for immunofluorescence staining. As a third alternative, cells were 
seeded in StemXVivo semi-solid medium (CCM012, R&D Systems Europe Ltd, Abingdon, UK) 
and cultured in poly-HEMA coated 24-well plates in order to grow as tumorspheres. 
 
Submental implantation model 
All mouse experiments were approved by the Ethics Committee for Animal Experimentation of 
Switzerland and performed following institutional guidelines. HNSCC cells were implanted in 
the neck of NMRI-nu immunodeficient mice (JANVIER LABS, Le Genest-Saint-Isle, France) as 
previously described [21]. 800,000 cells were resuspended in 30 µl HBSS (14175053, Gibco 
(Life Technologies Europe BV, Zug, Switzerland)), mixed with 20 µl BD Matrigel (356234, 
Becton Dickinson, Reinach, Switzerland) and subcutaneously injected along the submental 
midline of 8-week-old female NMRI-nu mice. Tumor volume was monitored using a Vernier 
caliper and calculated using the modified ellipsoid formula: Volume = 1/2 * (Length * (Width)2). 
Five days after implantation, FOXM1 down-regulation was initiated by providing 1 mg/ml Dox 
in drinking water containing 2% sucrose (35580.02, Serva (Witec AG, Sursee, Switzerland)). 
When tumors reached 150 mm3 they were dissected in pieces that were either collected by snap 
freezing in liquid nitrogen for downstream RNA extraction or fixed in 10% formalin (HT501128, 
Sigma-Aldrich Chemie GmbH) for histological evaluation. 
 
RNA-seq and Gene Set Enrichment Analysis (GSEA) 
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TruSeq stranded RNA library preparation and paired-end 100 bp read sequencing on an Illumina 
HiSeq 2500 machine were performed at the genomics facility of the University of Lausanne. The 
ENA study accession number is PRJEB29013. Transcripts were quantified using Salmon 
(v.0.8.2) [22]. Given the xenogeneic nature of the samples analyzed, the quantification was 
performed using an artificial hybrid transcriptome generated by merging Homo sapiens GRCh38 
and Mus musculus GRCm38 cDNA sequences to efficiently distinguish reads from human or 
mouse origin. Downstream analysis was performed in R (https://www.R-project.org) and is 
described in the supplementary material, Supplementary materials and methods. 
 
Histology, immunohistochemistry and immunofluorescence 
Hematoxylin and eosin staining were performed on formalin fixed paraffin embedded (FFPE) 
tumors or organotypes using standard procedure. Immunohistochemistry staining was performed 
on FFPE samples, the details of antibodies are listed in supplementary material, Supplementary 
materials and methods. Involucrin immunofluorescence was performed on PFA-fixed spheroids. 
Sections were permeabilized for 10 min at room temperature (RT) with 0.1% Triton X-100 then 
blocked for 30 min in PBS 0.5% BSA containing 1% donkey serum before incubation for 2 h at 
RT with a 1/200 antibody dilution in 0.5% BSA/PBS. After incubating 1 h at RT with donkey 
anti-mouse-A488 (A-21202, Life Technologies Europe BV) antibody diluted 1/500 in 
0.5%BSA/PBS, sections were mounted in ProLong Gold antifade reagent with DAPI (P-36931, 
Life Technologies Europe BV) and evaluated by fluorescence microscopy. 
Statistics 
This article is protected by copyright. All rights reserved.
 
  
 
The experimental results presented in the figures are generally representatives of at least three 
observations. Unless stated otherwise, the experimental data points in the figures represent the 
mean from triplicate experiments and the statistical significance of the data was determined using 
two-tailed Student’s t-test. 
 
For details of cell culture, 3D cell culture, RNA-seq and Gene Set Enrichment Analysis, 
chromatin immunoprecipitation, Alamar Blue assays, time-lapse cell tracking, double thymidine 
blocking, RNA isolation, RT-qPCR, image data analysis, immunohistochemistry and western 
blotting, please see supplementary material, Supplementary materials and methods. 
 
RESULTS 
 
Impact of FOXM1 knockdown on HNSCC cells in 2D and 3D cultures. 
 
To validate well-known in vitro activities of FOXM1 such as regulation of cell 
proliferation [23], migration and cellular invasion [24], we generated stable doxycycline (Dox)-
inducible shFOXM1- and shCtr-expressing CAL27, LAU2083 and LOD148 cell lines (Figure 
1A). FOXM1 knockdown using a validated construct [14] induced only slight (CAL27 and 
LOD148) or no difference (LAU2083) in cell proliferation (Figure 1B). Correspondingly, there 
were fewer cells in S-phase and slightly more cells in G2-phase upon shRNA-induced FOXM1 
knockdown (Figure 1C). Next, we monitored the expression of the cell cycle related genes 
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GTSE1 and CCNB2 (a known FOXM1 target) as read-out for the transcriptional activity of 
FOXM1. GTSE1 was identified amongst the top-genes that correlated with FOXM1 expression in 
the TCGA HNSCC dataset (Spearman's Rho 0.784), and we hypothesized that its promoter is a 
potential direct target of FOXM1. Using qChIP, we confirmed FOXM1-binding to the GTSE1 
promoter region in CAL27 cells as well as to the CCNB2 promoter (Figure 1D). However, 
GTSE1 expression in FOXM1-depleted cells was only slightly lower than in control cells (Figure 
1E), while the effect of FOXM1 downregulation on CCNB2 expression was more pronounced. 
Thus, we were unable to clearly confirm that FOXM1 regulates proliferation of HNSCC cells and 
expression of cell cycle related genes in vitro. 
There was also no major difference in respect to HGF-stimulated migration of control and 
FOXM1-depleted cells in a scratch wound healing assay (Figure 2A). Since HGF triggers the 
transcription of the FOS gene [25], an early-response transcription factor that stimulates 
expression of migration- and invasion-related genes such as PLAU (uPA) [26] and PLAUR 
(uPAR) [27], we looked at the expression of FOS and its target genes by RT-qPCR in HGF-
stimulated cells. The transcription of FOS was strongly induced 1 h after HGF stimulation, 
although it did not show a significant difference between control and FOXM1-depleted cells 
(Figure 2B). Three hours after HGF stimulation the expression of PLAUR in shCtr was slightly 
upregulated when compared to shFOXM1 cells, demonstrating that HGF-induced FOS activity 
seems to decline upon FOXM1 knockdown to some extent. Surprisingly, neither PLAU transcript 
levels, nor the abundance of its secreted product (uPA) changed upon FOXM1 knockdown in 
CAL27 cells (not shown). 
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To further evaluate the effect of FOXM1 knockdown on invasion, we used 3D 
organotypic culture (OT-culture) and assessed whether cancer-associated fibroblasts (CAFs), 
known to secrete HGF [28], would impact the invasive phenotype of the organotypes’ epithelial 
layer in a FOXM1-dependent manner. Indeed, mixing control cells with CAFs and seeding them 
on top of collagen I gel, resulted in a more invasive phenotype when compared to OT-cultures 
developed from shFOXM1 cells, as demonstrated by the quantification of budding or detaching 
cell groups (Figure 2C,D). 
Thus, our data demonstrate that shRNA-induced FOXM1 knockdown in HNSCC cells did 
not significantly impact on their capacity to proliferate and migrate under conditions of 2D 
culture. However, FOXM1 depletion resulted in a significant inhibition of cellular invasion in 
organotypic co-cultures with fibroblasts. 
 
FOXM1 knockdown reduces the number of proliferating cells in 3D OT-cultures. 
Next, we reasoned that the conditions of OT-culture are more physiological and hence 
more adequate to address the effect of FOXM1 knockdown. In OT-cultures, both shCtr and 
shFOXM1 CAL27 cells plated on top of collagen I (this time without CAFs to allow RT-qPCR 
analysis of cancer cells only) formed multilayered structures that in part resembled squamous 
epithelium (Figure 3A). Both control and shFOXM1 organotypes demonstrated widespread 
expression of keratins K14 (a marker of basal keratinocytes) and K8 (a marker of fetal epithelial 
differentiation in oral mucosa [29] that is aberrantly expressed in HNSCC [10]). In contrast, a 
slightly stronger expression of involucrin (a marker of squamous differentiation) and cells 
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positive for keratin K4 (a marker of mucosal differentiation) were observed in shFOXM1 
organotypes, while K18 (another marker of fetal epithelial differentiation) was substantially 
downregulated in FOXM1-depleted organotypes (Figure 3B). This phenotype was associated 
with upregulation of IVL transcripts and its upstream regulator JUND [30], as well as with a 
strong decrease in expression of the FOXM1 target genes CCNF [31] and GTSE1 in shFOXM1 
cells (Figure 3C). Although below the standard statistical significance threshold, a trend for 
upregulation of IVL upon FOXM1 knockdown could be confirmed in a large series of OT-
cultures (Figure 3D). Importantly, FOXM1 expression already decreased in shCtr cells upon 
transfer from 2D to OT-culture (Figure 3E), indicating that FOXM1 down-regulation is 
intrinsically associated with the activation of a differentiation program triggered upon 3D 
conditions of OT-culture. In the 3D context and in contrast to the minimal effect of FOXM1 
knockdown on proliferation observed in 2D culture, the association of FOXM1 with a 
proliferative state was confirmed by Ki-67 IHC staining of shCtr and shFOXM1 OT-cultures. 
Although at day 8 we observed a comparable number of Ki-67 positive cells mostly enriched at 
the basal layer (Figure 3F,G), at day 16, Ki-67 positive cells expanded throughout the control 
OT-culture, but not upon FOXM1 knockdown (Figure 3F,G). Thus, in OT-culture, the level of 
FOXM1 is decreased upon formation of a multilayered, epithelial-like tissue. Nonetheless, 
further reduction of FOXM1 expression by shRNA-induced knockdown results in a decreased 
amount of proliferating cells mostly trapped in the basal layer and facilitates progression towards 
a more differentiated-like phenotype. 
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FOXM1 knockdown limits tumor growth and affects tumor phenotype in a xenograft model. 
To find out whether effects of inducible FOXM1 knockdown observed in OT-cultures 
could be reproduced in vivo, control and shFOXM1-expressing cells were tested in the submental 
mouse model of HNSCC. In this model, human HNSCC cells injected into the submental region 
of immunodeficient mice initiate tumors featured by a squamous differentiation and 
heterogeneous expression of epithelial differentiation markers such as involucrin, keratins 8, 18, 
14 and 4 (supplementary material, Figure S1). In line with the reduced number of proliferating 
cells seen in OT-cultures, FOXM1 knockdown (induced from day 7 after implantation) 
significantly slowed down the growth kinetics of xenograft tumors (Figure 4A). In addition, 
FOXM1 knockdown also affected tumor invasion (Figure 4B). For each sagittal section through 
the tumor attached to the floor-of-the-mouth (FOM), we selected a series of regions of interest 
(ROI) and examined the orientation of the tumor border relative to the horizontal axis in these 
regions (left panel). Upon FOXM1 knockdown, the tumor borders were significantly less 
invasive, as demonstrated by the quantified reduction in their dispersion factor (a measure of the 
curvature of the border) (right panel). In addition, the ability of FOXM1-depleted cells to form 
large cohesive cords was significantly reduced. 
Histological analysis by H&E staining revealed an accelerated squamous differentiation 
by FOXM1 knockdown, as evidenced by formation of keratin pearls involving large areas 
(Figure 4C,D). However, immunostaining-based quantification of slightly upregulated keratin 1 
expression (a marker of terminal squamous differentiation) in shFOXM1 tumors did not reach 
statistical significance due to widespread expression of this marker in well-differentiated shCtr 
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tumors (Figure 4E,F). In shCtr tumors, multiple cells positive for FOXM1 staining were observed 
in the less differentiated areas (Figure 4G1) and sometimes located in a cell layer close to tumor 
stroma (Figure 4G2). Surprisingly, rare single cells (Figure 4G3) or patches of cells (Figure 4G4) 
showing nuclear expression of FOXM1 were detected in shFOXM1 tumors, indicating an 
incomplete knockdown in a fraction of cells. 
To analyze how FOXM1 knockdown globally affects the cancer cell transcriptome, 11 
tumor samples were subjected to transcriptome sequencing (RNA-seq). As xenograft tumors 
include both human and mouse cells, reads were aligned using an artificially created human-
mouse hybrid reference genome to ensure efficient and separate mapping of both human and 
mouse RNA sequencing reads. Owing to the different degrees of histologically evident squamous 
differentiation in shCtr samples and, respectively, to the varying level of FOXM1 expression and 
significant variations in FOXM1 knockdown efficiency in shFOXM1 samples, paired group 
analysis was not possible. Therefore, we used DEseq2 [32] to perform a correlative analysis of 
genes that were positively or negatively associated with FOXM1 expression and used the 
resulting Wald statistics value (supplementary material, Table S1) as a metric to define a ranked 
list of genes for downstream gene set enrichment analysis (GSEA). Figure 5A (upper panels) 
illustrates positive and negative correlations with the level of FOXM1 expression showing 
GTSE1 and IVL genes as examples. The inverse correlations between FOXM1 and 
differentiation-related genes such as IVL and KRT1 were further confirmed by RT-qPCR in a 
larger number of RNA samples extracted from shCtr and shFOXM1 CAL27 xenograft tumors 
(Figure 5B). Notably, our results are in agreement with RNA-seq data from the TCGA HNSCC 
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dataset (Figure 5A, lower panels). In general, the top of the ranked list of genes was enriched in 
proliferation gene sets (e.g., G2-M cell cycle and EGFR signaling), while genes at the bottom of 
the ranked list were enriched in differentiation-related gene sets (Figure 5C, supplementary 
material, Table S2). Furthermore, clustering analysis using a differentiation-related subset of 
genes including keratin-coding genes revealed differential expression in our RNA-seq samples 
(supplementary material, Figure S2) and in the TCGA-HNSCC dataset (supplementary material, 
Figure S3), which can likely be attributed to deregulated mechanisms of squamous-like 
differentiation. Interestingly, in the TCGA dataset FOXM1 expression tends to be associated with 
cancers originating at the base of tongue and tonsils including HPV-related cases. In addition, 
FOXM1 clustered with simple epithelial-type keratins (K7, K8, K18, and K19) and basal 
keratinocyte keratin K15, suggesting a possible association of FOXM1 with traits of the fetal 
differentiation program.Altogether, by analyzing the effects of FOXM1 knockdown in HNSCC 
xenograft model we concluded that FOXM1 plays a key role in the tightly regulated balance of 
cancer cell proliferation versus differentiation. 
 
Ectopic FOXM1 reduces expression of differentiation markers in HNSCC cell lines. 
Finally, we provide complementary evidence that ectopic FOXM1 overexpression is 
accompanied by a less differentiated phenotype in a series of four head and neck cancer cell lines 
(Figure 6). Following immunoblotting in 2D cultures, we confirmed the downregulation of 
involucrin upon FOXM1 overexpression in LOD148, LAU2083 and LAU2088 cells, whereas 
keratin 1 was downregulated in LAU2083 and LAU2088 cells (Figure 6A). To further validate 
This article is protected by copyright. All rights reserved.
 
  
 
the effect of ectopic FOXM1 on squamous-like differentiation, cells were cultured in 3D, either 
using collagen embedding or in semi-solid StemXVivo medium. LAU2083 and LAU2088 cells 
did not grow as spheroids, however CAL27 and LOD148 grew as spheroids (in collagen I gel) or 
as aggregates of cells (in StemXVivo medium) and confirmed the downregulation of IVL 
expression following FOXM1 overexpression (Figure 6B). Finally, immunostaining confirmed 
involucrin reduction upon FOXM1 overexpression in CAL27 collagen-embedded spheroids, as 
demonstrated by the reduced area of involucrin-positive cells within the spheroids (Figure 6C). 
 
DISCUSSION 
In this study, we demonstrated that the cell cycle promoting function of FOXM1 is 
context dependent in HNSCC and only evident under conditions of 3D culture and in tumor 
xenografts. Although mechanisms of FOXM1 action in the regulation of cell cycle in cancer cells 
are well explored [4], its role in controlling their cell fate decisions is largely unknown, in 
particular in SCCs which are characterized by complex patterns of deregulated differentiation 
states. Our work provides novel insight into the function of FOXM1 in such tumors 
demonstrating its supporting role in counterbalancing an aberrant squamous differentiation of 
HNSCC.  
Mechanisms that govern normal differentiation towards stratified mucosal epithelia are 
impaired in HNSCC due to genetic and epigenetic alterations. An aberrant squamous 
differentiation program is evident in HNSCC by intra- and inter-tumor heterogeneity in 
morphological appearance paralleled by variable expression of differentiation-specific proteins 
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such as keratins [10,11]. In this respect, acquisition of the traits of fetal tissues (such as 
expression of simple epithelial-type keratins 8, 18 and 19) and developmental plasticity could be 
beneficial for growth and dissemination of cancer cells, as it may confer a survival advantage in a 
distinct microenvironment and upon anti-cancer treatment. Therefore, unraveling most critical 
pathways that trigger and control differentiation programs in HNSCC is urgently needed to 
discover actionable targets and to redirect cancer cell phenotype towards a less aggressive state. 
Accordingly, targeted induction of terminal differentiation may reduce tumor invasion as has 
been demonstrated by ectopic overexpression of S100A16, a EF-hand calcium binding protein of 
the S100 protein family, in HNSCC cell lines [33]. 
The loss of a malignant phenotype upon the induction of differentiation has been 
exploited in the past in particular in hematological malignancies and coined differentiation 
therapy [34]. The most pertinent example is the treatment of acute promyelocytic leukemia 
(APL) with all-trans retinoic acid (ATRA) which results in a high rate of complete remissions 
[35]. Differentiation strategies to treat solid cancers are more difficult to realize because of their 
genetic heterogeneity and dependence on a complex combination of oncogenic pathways [34]. In 
HNSCC cells, retinoids are effective as anti-proliferative agents [36] that inhibit growth of tumor 
xenografts [37]. Not surprisingly, the proliferation-inhibitory effect of ATRA and bexarotene (a 
pan-RXR agonist) is associated with FOXM1 downregulation [38]. How FOXM1 regulates the 
tightly coordinated balance between proliferation and differentiation of HNSCC cells and 
whether this mode of action depends on direct or indirect interactions with other transcriptional 
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regulators of squamous differentiation such as p63 [39] or the ETS2/ELK3-AP1-SOX2-KLF5 
network [40] remains to be elucidated. 
It is intriguing to speculate that the retained ability to trigger a fetal differentiation 
program of oral mucosa and eventually acquire a reversible differentiation state may be 
advantageous to SCCs serving as an alternative to epithelial-to-mesenchymal transition (EMT) 
for survival. While proliferating cells are more sensitive to genotoxic drugs, differentiation may 
rescue a fraction of non-dividing, committed cancer stem cells (CSCs) from the treatment, 
especially if the process can be halted before the cells reach a state of permanent differentiation 
and reverse back to a proliferative state. In support of this idea, it has been reported that tumor 
cells re-growing after chemotherapy seem to originate from layers of cells directly surrounding 
hypoxic well-differentiated areas, which due to a scarce vascularization are insufficiently 
accessible for cytotoxic drugs [41]. Also, survival of residual cancer cells, which remain after 
surgery in the tumor surrounding area, may depend on their aptitude to switch reversibly into a 
dormant state via incomplete squamous differentiation and resume proliferation upon favorable 
conditions. In this respect, targeting of FOXM1 using specific inhibitors, such as RCM-1 [42], 
combined with a standard-of-care concurrent chemo-radiotherapy may potentially give an 
advantageous therapeutic effect.  
In summary, FOXM1 being widely expressed in human cancers and in particular 
HNSCCs emerges as an interesting actionable target. Before that, preclinical investigations will 
have to address the potential and mechanisms of differentiation-promoting and invasion-
inhibiting therapy using FOXM1 inhibitors in HNSCCs. 
This article is protected by copyright. All rights reserved.
 
  
 
 
Acknowledgements 
The authors would like to thank Professor Massimo Bongiovanni (Lausanne University Hospital) 
for his help in the histopathological assessment of tumor sections. This work was supported by 
DACH-DFG/SNF joint grant (310030L_144267 to CS and HE5760/3-1 to JH) and SNF grant 
(310030_152875 to GVT), the Faculty of Biology and Medicine of the University of Lausanne 
(to CS), the Swiss Cancer Research foundation (KLS-3853-02-2016-R to GVT and YM), and the 
Fondation pour la lutte contre le cancer (to GVT). We are indebted to animal caretakers at the 
UNIL animal facility for their daily support in the mouse experiments, to the Mouse Pathology 
(Janine Horlbeck and Jean-Christophe Stehle) and Cellular Imaging (Florence Morgenthaler and 
Yannick Krempp) facilities at the UNIL (for tissue sample processing and imaging), and to Antje 
Schuhmann for excellent technical assistance (IHC staining and images). 
 
Author contributions statement 
Conceptualization, CS and GVT. Methodology, VR, AHF, VM, JPR, JH, GVT. Software, VR. 
Formal analysis, VR, AHF, JPR. Investigation, VR, AHF, VM, JPR, JS, MTT, SFL, ZT, MM. 
Resources, YM, JH, GVT, CS. Writing – original draft, VR, GVT, CS. Writing – review and 
editing, VR, MTT, JH, GVT, CS. Supervision, JPR, CS, GVT. Funding acquisition, CS, JH, YM, 
GVT. 
 
  
This article is protected by copyright. All rights reserved.
 
  
 
 
REFERENCES 
 
1. Golson ML, Kaestner KH. Fox transcription factors: from development to disease. 
Development 2016; 143: 4558–4570. 
2. Bella L, Zona S, Nestal de Moraes G, et al. FOXM1: A key oncofoetal transcription 
factor in health and disease. Semin Cancer Biol 2014; 29: 32–39. 
3. Gartel AL. FOXM1 in cancer: interactions and vulnerabilities. Cancer Res 2017; 77: 
3135–3139. 
4. Fischer M, Muller GA. Cell cycle transcription control: DREAM/MuvB and RB-E2F 
complexes. Crit Rev Biochem Mol Biol 2017; 52: 638–662. 
5. Wierstra I. The transcription factor FOXM1 (Forkhead box M1): proliferation-specific 
expression, transcription factor function, target genes, mouse models, and normal 
biological roles. Adv Cancer Res 2013; 118: 97–398. 
6. Yao S, Fan LY, Lam EW. The FOXO3-FOXM1 axis: A key cancer drug target and a 
modulator of cancer drug resistance. Semin Cancer Biol 2018; 50: 77–89. 
7. Gentles AJ, Newman AM, Liu CL, et al. The prognostic landscape of genes and 
infiltrating immune cells across human cancers. Nat Med 2015; 21: 938–945. 
8. Leemans CR, Braakhuis BJ, Brakenhoff RH. The molecular biology of head and neck 
cancer. Nat Rev Cancer 2011; 11: 9–22. 
9. Dotto GP, Rustgi AK. Squamous cell cancers: a unified perspective on biology and 
genetics. Cancer Cell 2016; 29: 622–637. 
10. Matthias C, Mack B, Berghaus A, et al. Keratin 8 expression in head and neck epithelia. 
BMC Cancer 2008; 8: 267. 
11. Regenbogen E, Mo M, Romeiser J, et al. Elevated expression of keratin 17 in 
oropharyngeal squamous cell carcinoma is associated with decreased survival. Head Neck 
2018; 40: 1788–1798. 
12. Sakamoto K, Aragaki T, Morita K, et al. Down-regulation of keratin 4 and keratin 13 
expression in oral squamous cell carcinoma and epithelial dysplasia: a clue for 
histopathogenesis. Histopathology 2011; 58: 531–542. 
13. Hwang S, Mahadevan S, Qadir F, et al. Identification of FOXM1-induced epigenetic 
markers for head and neck squamous cell carcinomas. Cancer 2013; 119: 4249–4258. 
14. Tanaka N, Zhao M, Tang L, et al. Gain-of-function mutant p53 promotes the oncogenic 
potential of head and neck squamous cell carcinoma cells by targeting the transcription 
factors FOXO3a and FOXM1. Oncogene 2018; 37: 1279–1292. 
15. Teh MT, Gemenetzidis E, Patel D, et al. FOXM1 induces a global methylation signature 
that mimics the cancer epigenome in head and neck squamous cell carcinoma. PLoS One 
2012; 7: e34329. 
This article is protected by copyright. All rights reserved.
 
  
 
16. Teh MT, Hutchison IL, Costea DE, et al. Exploiting FOXM1-orchestrated molecular 
network for early squamous cell carcinoma diagnosis and prognosis. Int J Cancer 2013; 
132: 2095–2106. 
17. Gemenetzidis E, Bose A, Riaz AM, et al. FOXM1 upregulation is an early event in 
human squamous cell carcinoma and it is enhanced by nicotine during malignant 
transformation. PLoS One 2009; 4: e4849. 
18. Gemenetzidis E, Costea DE, Parkinson EK, et al. Induction of human epithelial 
stem/progenitor expansion by FOXM1. Cancer Res 2010; 70: 9515–9526. 
19. Molinuevo R, Freije A, de Pedro I, et al. FOXM1 allows human keratinocytes to bypass 
the oncogene-induced differentiation checkpoint in response to gain of MYC or loss of 
p53. Oncogene 2017; 36: 956–965. 
20. Smirnov A, Panatta E, Lena A, et al. FOXM1 regulates proliferation, senescence and 
oxidative stress in keratinocytes and cancer cells. Aging 2016; 8: 1384–1397. 
21. Roh V, Abramowski P, Hiou-Feige A, et al. Cellular barcoding identifies clonal 
substitution as a hallmark of local recurrence in a surgical model of head and neck 
squamous cell carcinoma. Cell Rep 2018; 25: 2208–2222 e2207. 
22. Patro R, Duggal G, Love MI, et al. Salmon provides fast and bias-aware quantification of 
transcript expression. Nat Methods 2017; 14: 417–419. 
23. Kim IM, Ackerson T, Ramakrishna S, et al. The Forkhead Box m1 transcription factor 
stimulates the proliferation of tumor cells during development of lung cancer. Cancer Res 
2006; 66: 2153–2161. 
24. Chen CH, Chien CY, Huang CC, et al. Expression of FLJ10540 is correlated with 
aggressiveness of oral cavity squamous cell carcinoma by stimulating cell migration and 
invasion through increased FOXM1 and MMP-2 activity. Oncogene 2009; 28: 2723–
2737. 
25. Fabregat I, de Juan C, Nakamura T, et al. Growth stimulation of rat fetal hepatocytes in 
response to hepatocyte growth factor: modulation of c-myc and c-fos expression. Biochem 
Biophys Res Commun 1992; 189: 684–690. 
26. Nerlov C, De Cesare D, Pergola F, et al. A regulatory element that mediates co-operation 
between a PEA3-AP-1 element and an AP-1 site is required for phorbol ester induction of 
urokinase enhancer activity in HepG2 hepatoma cells. EMBO J 1992; 11: 4573–4582. 
27. Dang J, Boyd D, Wang H, et al. A region between -141 and -61 bp containing a proximal 
AP-1 is essential for constitutive expression of urokinase-type plasminogen activator 
receptor. Eur J Biochem 1999; 264: 92–99. 
28. Knowles LM, Stabile LP, Egloff AM, et al. HGF and c-Met participate in paracrine 
tumorigenic pathways in head and neck squamous cell cancer. Clin Cancer Res 2009; 15: 
3740–3750. 
29. Pelissier A, Ouhayoun JP, Sawaf MH, et al. Changes in cytokeratin expression during the 
development of the human oral mucosa. J Periodontal Res 1992; 27: 588–598. 
This article is protected by copyright. All rights reserved.
 
  
 
30. Welter JF, Crish JF, Agarwal C, et al. Fos-related antigen (Fra-1), junB, and junD activate 
human involucrin promoter transcription by binding to proximal and distal AP1 sites to 
mediate phorbol ester effects on promoter activity. J Biol Chem 1995; 270: 12614–12622. 
31. Chen X, Muller GA, Quaas M, et al. The forkhead transcription factor FOXM1 controls 
cell cycle-dependent gene expression through an atypical chromatin binding mechanism. 
Mol Cell Biol 2013; 33: 227–236. 
32. Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for 
RNA-seq data with DESeq2. Genome Biol 2014; 15: 550. 
33. Sapkota D, Bruland O, Parajuli H, et al. S100A16 promotes differentiation and 
contributes to a less aggressive tumor phenotype in oral squamous cell carcinoma. BMC 
Cancer 2015; 15: 631. 
34. de The H. Differentiation therapy revisited. Nat Rev Cancer 2018; 18: 117–127. 
35. Slack JL. The biology and treatment of acute progranulocytic leukemia. Curr Opin Oncol 
1999; 11: 9–13. 
36. Zou CP, Youssef EM, Zou CC, et al. Differential effects of chromosome 3p deletion on 
the expression of the putative tumor suppressor RAR beta and on retinoid resistance in 
human squamous carcinoma cells. Oncogene 2001; 20: 6820–6827. 
37. Shalinsky DR, Bischoff ED, Lamph WW, et al. A novel retinoic acid receptor-selective 
retinoid, ALRT1550, has potent antitumor activity against human oral squamous 
carcinoma xenografts in nude mice. Cancer Res 1997; 57: 162–168. 
38. Osei-Sarfo K, Gudas LJ. Retinoids induce antagonism between FOXO3A and FOXM1 
transcription factors in human oral squamous cell carcinoma (OSCC) cells. PLoS One 
2019; 14: e0215234. 
39. Gatti V, Fierro C, Annicchiarico-Petruzzelli M, et al. DeltaNp63 in squamous cell 
carcinoma: defining the oncogenic routes affecting epigenetic landscape and tumour 
microenvironment. Mol Oncol 2019; 13: 981–1001. 
40. Yang H, Schramek D, Adam RC, et al. ETS family transcriptional regulators drive 
chromatin dynamics and malignancy in squamous cell carcinomas. eLife 2015; 4: e10870. 
41. Bhattacharya A, Toth K, Mazurchuk R, et al. Lack of microvessels in well-differentiated 
regions of human head and neck squamous cell carcinoma A253 associated with 
functional magnetic resonance imaging detectable hypoxia, limited drug delivery, and 
resistance to irinotecan therapy. Clin Cancer Res 2004; 10: 8005–8017. 
42. Shukla S, Milewski D, Pradhan A, et al. The FOXM1 Inhibitor RCM-1 Decreases 
Carcinogenesis and Nuclear beta-Catenin. Mol Cancer Ther 2019; 18: 1217–1229. 
*43. Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a 
knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl 
Acad Sci U S A 2005; 102: 15545–15550. 
*44. Cao S, Wendl MC, Wyczalkowski MA, et al. Divergent viral presentation among human 
tumors and adjacent normal tissues. Sci Rep 2016; 6: 28294. 
This article is protected by copyright. All rights reserved.
 
  
 
*45. Quante T, Otto B, Brazdova M, et al. Mutant p53 is a transcriptional co-factor that binds 
to G-rich regulatory regions of active genes and generates transcriptional plasticity. Cell 
Cycle 2012; 11: 3290–3303. 
*46. Untergasser A, Cutcutache I, Koressaar T, et al. Primer3--new capabilities and interfaces. 
Nucleic Acids Res 2012; 40: e115. 
*47. Spandidos A, Wang X, Wang H, et al. PrimerBank: a resource of human and mouse PCR 
primer pairs for gene expression detection and quantification. Nucleic Acids Res 2010; 38: 
D792–799. 
*48. Dierck K, Machida K, Mayer BJ, et al. Profiling the tyrosine phosphorylation state using 
SH2 domains. Methods Mol Biol 2009; 527: 131–155, ix. 
 
 
*Cited only in supplementary material. 
 
This article is protected by copyright. All rights reserved.
 
  
 
FIGURE LEGENDS: 
Figure 1. shRNA-induced FOXM1 knockdown has minimal effect in 2D cell culture. (A) 
Inducible FOXM1 protein down-regulation in the presence of doxycycline (Dox) was confirmed 
by immunoblotting in three HNSCC cell lines. (B) The effect of FOXM1 knockdown on cell 
growth in all cell lines was very limited as measured by an Alamar Blue assay. Mean± SEM. (C) 
The cell cycle profile of FOXM1-depleted CAL27 cells following double thymidine block was 
assessed at the indicated time points. The increased number of cells in G2-phase was the only 
relevant difference observed in FOXM1-depleted cells. Each point represents an independent 
measure. (D) FOXM1 binding to GTSE1 and CCNB2 promoters was confirmed by qChIP. 
Efficient binding was observed independently on the presence of Dox or HGF. (E) RT-qPCR 
analysis confirmed the sustained down-regulation of FOXM1 throughout cell cycle. While a 
substantial reduction in CCNB2 mRNA was observed, GTSE1 mRNA expression was only 
slightly reduced in FOXM1-depleted cells. Each point represents one measure from three 
independent experiments. 
 
Figure 2. shRNA-induced knockdown of FOXM1 impairs invasion in organotypic co-
culture with CAFs. (A) Cell motility in presence of HGF was assessed in three cell lines by 
cellular tracking. The relative speed (distance covered per frame recorded) was independent on 
FOXM1 knockdown. Each data point represents one tracked cell. (B) RT-qPCR analysis of 
FOXM1, FOS and PLAUR expression following FOXM1 knockdown and stimulation with HGF 
(50 ng/ml). While FOXM1 was efficiently downregulated, the reduction in FOS and PLAUR 
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transcription was only suggestive of a trend and did not reach statistical significance (Student’s t-
test). Data represent three independent biological replicates. (C) H&E staining of CAL27 
organotypic co-cultures with CAFs demonstrating an inhibition of budding as well as detached 
cellular invasion following FOXM1 knockdown. Scale bar, 100 µm. (D) Quantification of the 
invasion patterns observed in panel (C) showing a reduction following FOXM1 knockdown. 
Each point represents one analyzed culture (Student’s t-test). 
 
Figure 3. shRNA-induced FOXM1 knockdown decreases the number of proliferating cells 
and facilitates progression towards a more differentiated-like phenotype. (A) H&E staining 
of CAL27 organotypic cultures demonstrating a squamous-like phenotype after 16 days of 
culture. Scale bar, 100 µm. (B) Representative pictures of an immunostaining for a series of 
indicated differentiation markers in CAL27 organotypic cultures at day 16. Scale bar, 100 µm. 
(C) RT-qPCR analysis of organotypes showing a gradual decrease in FOXM1 and its targets 
CCNF and GTSE1 upon FOXM1 knockdown while differentiation-related genes such as JUND 
and IVL were upregulated both by FOXM1 knockdown and increased time of culture. Data 
shown are from one experiment. (D) RT-qPCR analysis of FOXM1 and IVL expression levels in 
a large series of CAL27 shCtr or shFOXM1 organotypic cultures showing a trend for IVL 
upregulation following FOXM1 knockdown. Each dot represents one organotype. (E) FOXM1 
expression was reduced by culturing cells in 3D organotypes as demonstrated by the reduction of 
FOXM1 mRNA measured by RT-qPCR. Each data point represents one sample under one 
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condition or the other. (F) Computer-assisted quantification of the number of Ki-67-positive cells 
detected by immunohistochemistry in shCtr and FOXM1-depleted organotypes. Each data point 
represents one analyzed field of the organotype. (G) Examples for the Ki-67 
immunohistochemistry data quantified in panel (F). Ki-67-positive cells were detected in the 
basal layer for both conditions at day 8. In the control, cycling cells were present throughout the 
organotype at day 16, while they were restricted to the basal layer upon FOXM1 down-
regulation. Scale bar, 100 µm. 
 
Figure 4. shRNA-induced FOXM1 knockdown delays tumor growth and promotes a 
squamous-like phenotype in vivo. (A) Tumor growth upon submental implantation of CAL27 
cells in nude mice. FOXM1 knockdown resulted in a significant delay in tumor growth (Student’s 
t-test) up to day 35. At this point, the sacrifice of four mice with bigger tumors in the shCtr group 
(ethical endpoint) resulted in the loss of significant difference between groups at day 42. (B) 
Based on histological evaluation of a series of hotspots randomly selected in xenograft tumors 
stained by H&E (left panel), the degree of cellular invasion was quantified using Fiji’s 
directionality analysis tool and inferring the curvature of the tumor border with the dispersion 
index (right panel). Tumor borders from FOXM1-depleted tumors showed less aggressive 
invasion patterns (Student’s t-test). Data points represent the mean dispersion value in each 
animal. (C) Tumor-bearing FOM were stained by H&E to examine the extent of squamous 
differentiation. One example H&E staining is shown for each condition. (D) Boxplot showing the 
This article is protected by copyright. All rights reserved.
 
  
 
mean differentiated area in tumors grown from shCtr or shFOXM1 cells. The extent of 
differentiation in tumors increased significantly upon FOXM1 knockdown (Student’s t-test). 
Each point represents one tumor. (E) Quantification of keratin 1 immunohistochemistry staining 
performed on shCtr and shFOXM1 tumor confirming a trend for keratin 1 upregulation upon 
FOXM1 knockdown. Each point represents one tumor. (F) One example of keratin 1 staining for 
each group. Scale bar, 100 µm. (G) FOXM1 immunohistochemistry was performed on shCtr and 
FOXM1-depleted tumors. Scale bar, 50 µm. 
 
Figure 5. Differentiation markers are inversely correlated with FOXM1 in vivo. (A) 
Xenograft tumors analyzed by RNA-seq showed that FOXM1 expression (measured by 
logarithmic read counts) was positively correlated with GTSE1 expression, while it was inversely 
correlated with IVL expression (top). These correlations were validated in the TCGA HNSCC 
dataset (bottom). (B) RT-qPCR analysis confirming the inverse correlation of FOXM1 expression 
with the differentiation markers IVL (top) and KRT1 (bottom) in a larger group of xenograft 
tumors. (C) GSEA plots showing that a significant cluster of genes positively correlated with 
FOXM1 expression (based on RNA-seq analysis) was listed in the Kobayashi EGFR signaling 
gene set (left), while another significant cluster of genes negatively correlated with FOXM1 was 
listed in Rickman’s well-differentiated tumor gene set (right). 
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Figure 6. Overexpression of FOXM1 impairs differentiation in spheroid cultures of HNSCC 
cells. (A) Immunoblotting analysis of differentiation markers upon ectopic FOXM1 
overexpression in a series of HNSCC cell lines. (B) RT-qPCR analysis of FOXM1 (left panels) 
and IVL (right panels) mRNA expression in 3D spheroids (in collagen I gel) and tumorsphere 
cultures (in StemXVivo medium) upon FOXM1 overexpression. Each point represents one 
culture. (C) (left panel) Immunostaining analysis of control (mCherry) or FOXM1-
overexpressing CAL27 spheroids confirming the reduction of involucrin-positive cells within 
spheroids following FOXM1 overexpression. Scale bar, 200 µm. (right panel) Quantification 
data. Each point represents one spheroid. FOXM1: FOXM1 overexpression. mCh: mCherry 
control vector. 
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Figure S1. Differentiation markers in xenograft tumors. 
Figure S2. Heatmap clustering of differentiation markers in RNA-seq data from xenograft 
tumors. 
Figure S3. Heatmap clustering of differentiation markers in the TCGA HNSCC dataset. 
Table S1. List of genes and their associated correlation factor with FOXM1 as calculated by 
DEseq2. 
Table S2. GSEA report for gene sets correlating with FOXM1 expression. 
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